What is Pacira BioSciences, Inc.'s non-cash interest expense?

Pacira BioSciences, Inc. (PCRX) reported non-cash interest expense of $577K in Q1 2026.

How has Pacira BioSciences, Inc.'s non-cash interest expense changed year-over-year?

Pacira BioSciences, Inc.'s non-cash interest expense decreased by 33.4% year-over-year, from $867K to $577K.

Pacira BioSciences, Inc. PCRX Non-cash interest expense

Non-cash interest expense at other companies

Collegium Pharmaceutical, Inc.COLL

——

Other financials

Income statement

See full

Revenue$177.4M+5.0%

Gross profit$141.0M+4.7%

Operating income$6.9M+247%

Net income$2.9M-39.4%

EPS (diluted)$0.07-30.0%

Balance sheet

See full

Cash & equivalents$144.3M-49.1%

Total debt$411.2M+15.3%

Total equity$653.9M-18.1%

Total assets$1.2B-23.8%

Cash flow

See full

Operating cash flow$25.7M-27.6%

CapEx$2.7M-68.1%

Free cash flow$23.0M-14.7%

Valuation

See full

Market cap$942.78M-14.5%

Enterprise value$1.21B+2.6%

P/E183.5×—

P/S1.3×-0.3×

Profitability

See full

Gross margin79.3%+1.7pp

Operating margin3.3%—

Net margin0.7%—

FCF margin18.1%-4.6pp

Returns & leverage

See full

Return on equity0.7%—

Debt / equity0.6×+0.2×

Current ratio4.7×+2.3×

Where this comes from

Reported directly by Pacira BioSciences, Inc. in its filing.

Tagged under the XBRL concept us-gaap:AmortizationOfFinancingCostsAndDiscounts.

The official record: Pacira BioSciences, Inc.’s 10-Q, filed April 30, 2026, on SEC EDGAR. View the filing →

Ask your AI about Pacira BioSciences, Inc.'s non-cash interest expense.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Pacira BioSciences, Inc.'s non-cash interest expense?: Pacira BioSciences, Inc. (PCRX) reported non-cash interest expense of $577K in Q1 2026.
How has Pacira BioSciences, Inc.'s non-cash interest expense changed year-over-year?: Pacira BioSciences, Inc.'s non-cash interest expense decreased by 33.4% year-over-year, from $867K to $577K.